by Alex Kadhim
A recent study, published in Blood Advances, has identified that pre-hematopoietic stem cell transplant (HSCT) conditioning induces the extracellular release of damaged mitochondria, exacerbating...
by Alex Kadhim
A recent study, published in Cell, has identified the circadian rhythm of tumor-infiltrating lymphocytes (TILs) as a key determinant in the efficacy of immunotherapy treatments such as chimeric...
by Clinical & Translational Immunology
Researchers have identified a non-functional variant of the P2X purinocepter 7 (npP2X7) receptor as a promising target for chimeric antigen receptor (CAR) T-cell treatment in patients with ovarian...
by Blood
The efficacy of anti-CD19 chimeric antigen receptor T-cells (CD19-CAR) against relapsed/refractory B-cell malignancies can be amplified by co-administering them alongside CD20-targeting bispecific...
by July 2024 Advocacy Update
3rd Annual ACCESS Initiative Workshop: Access and Outcomes
by Blood Advances
Researchers have found that absolute lymphocyte count (ALC) following BCMA-directed chimeric antigen receptor (CAR) T-cell treatment can help predict which patients with relapsed/refractory...